Phase 3 Trial Shows Investigational Arzoxifene Superior to Evista® (raloxifene HCl) in Women with Osteoporosis http://is.gd/oIji
Links shared publicly online about this topic.
- 2,167total visits
Phase 3 Trial Shows Investigational Arzoxifene Superior to Evista® (raloxifene HCl) in Women with Osteoporosis http://is.gd/oIji
Phase 3 Trial Shows Investigational Arzoxifene Superior to Evista® (raloxifene HCl) in Women with Osteoporosis http://is.gd/oIji
View full resource at newsroom.lilly.com
Tags: Osteoporosis, Osteoporosis Medication, Phase 3 Clinical Trial, Women's Health, Evista
Most Recently Shared on March 24, 2009 at 2:18 pm By:
Phase 3 Trial Shows Investigational Arzoxifene Superior to Evista® (raloxifene HCl) in Women with Osteoporosis http://is.gd/oIji
Advertisement
